Page 6 - 《中国药房》2023年4期
P. 6

Efficacy and safety of parecoxib versus ketorolac tromethamine for perioperative analgesia: a systematic review
            ⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅ LIN Mao,HU Zhiqiang,CHEN Ya,XIAO Hongtao,JIANG Qian (476)
          Meta-analysis of the efficacy and safety of immune checkpoint inhibitors in the treatment of metastatic colorectal
            cancer  ⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅ CHEN Wei,CHEN Jiayi,LI Ling,YU Junxian (482)
          Discussion on the concept of collaboration between clinical pharmacists and physicians in China  ⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅
            ⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅ WANG Chenyu,HUANG Yuankai,XI Xiaoyu (487)
          Establishment and application of path-based management mode of 5-HT3 receptor antagonists in chemotherapy
            patients ⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅ GAO Lu,LI Jing,ZHOU Xiao,HUANG Yuan,YU Lin,SONG Huizhu,YANG Yuhua (493)
          Research progress of thrombolytic drugs for acute ischemic stroke ⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅ KONG Weilin,YANG Qingwu (497)
          Application progress of parallel artificial membrane permeation assay model in drug permeability screening of
            transdermal drug delivery system ⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅ SONG Sankong,BAI Yinliang,LIANG Jiandi (502)

          Research progress and clinical application of liposomal drug delivery system ⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅
            ⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅ GU Wenrui,YANG Ya,MA Huan,XIA Peiyuan (508)


























              CHINA    PHARMACY    (Semimonthly)
                           Founded  in  January  1990
                    Vol.34,  No.4,  Feb.  2023
          Total  No.742  Published  on   Feb.  28,2023


          Responsible  Institution                                Phone
          National  Health  Commission,P.R. China                 +86-23-63830521;+86-23-63830907;+86-23-68586727;
          Sponsored  by                                           +86-23-68586827
          Chinese  Hospital  Association                          E-mail
          Chongqing  University  Cancer  Hospital                 info@china-pharmacy.com
          Edited  by                                              Website
          China  Pharmacy  Editorial  and  Publishing  Center     http://www.china-pharmacy.com
          Director  of  Editorial  Commission                     Online  Submission
          LI  Linkang                                             http://user.china-pharmacy.com
          Executive  Deputy  Director  of  Editorial  Commission   Printed  by
          WU  Yongzhong                                           Chongqing  Changhong  Printing  Co.,  Ltd.
          Chief  of  Center                                       Distributed  by
          ZOU  Xiaoyong                                           China:  Chongqing  Post  Offices(Code  No.78-33)
          Editor-in-Chief                                         Overseas:  China  International  Book  Trading  Corporation
          HU  Xin
          Vice  Editor-in-Chief                                  (Code  No.4703SM)
          LENG  Huaiming                                          Subscription  Rates
          Chief  Editor                                           CNY 15 per issue;CNY 360 per annum
          ZHANG  Jian                                             CSSN   ISSN  1001-0408
          Published  by                                                 CN  50-1055/R
          China  Pharmacy  Editorial  Department                  CODEN
          Postal  Address                                         ZYHAA4
          129  Daping  Main  Street,Yuzhong  District,Chongqing   Perennial  Legal  Counsel
          400042,China                                            Chongqing  Huali  Wantao  Law  Firm
   1   2   3   4   5   6   7   8   9   10   11